Phase-II Clinical Trial Evaluating Guanfacine for Smoking Cessation
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 11 Nov 2017
At a glance
- Drugs Guanfacine (Primary)
- Indications Smoking withdrawal
- Focus Therapeutic Use
- 06 Nov 2017 Planned End Date changed from 1 Apr 2018 to 1 Apr 2019.
- 06 Nov 2017 Planned primary completion date changed from 1 Nov 2017 to 1 Nov 2018.
- 06 Nov 2017 Status changed from recruiting to active, no longer recruiting.